Narita I, Border W A, Ketteler M, Noble N A
Division of Nephrology, University of Utah School of Medicine, Salt Lake City.
Lab Invest. 1995 Jan;72(1):17-24.
Nitric oxide (NO), produced from L-arginine by an inducible NO synthase, is an important effector molecule in inflammatory and immunologic tissue injury. The role of NO generation in immunologic injury to glomerular mesangial cells and the effect of dietary restriction of L-arginine on this injury was investigated.
Acute glomerulonephritis was induced by injection of anti-thymocyte serum (ATS) which binds to an antigen on the glomerular mesangial cell. Complement-mediated mesangial cell lysis follows. The effect of blocking NO production in vivo by administration of the NOS inhibitor NG-monomethyl-L-arginine (L-NMMA) 60 minutes before ATS injection on mesangial cell lysis, and on the severity of disease was assessed. The effect of dietary restriction of L-arginine on mesangial cell lysis in response to ATS injection was also determined.
We report here that blocking NO production in vivo with L-NMMA prevented mesangial cell lysis by 90%. Injection of L-NMMA caused transiently elevated systolic blood pressure, but did not diminish ATS binding to mesangial cells or recruitment of monocyte/macrophages into glomeruli indicating that L-NMMA pretreatment did not limit injury by insufficient glomerular perfusion. ATS-induced proteinuria and increases in urinary nitrite excretion were prevented. Glomerular expression of transforming growth factor-beta and accumulation of extracellular matrix were suppressed by the L-NMMA treatment. Low protein diet (6%), but also selective dietary L-arginine restriction, given for 7 days before induction of the disease mimicked L-NMMA treatment, significantly decreasing mesangial cell lysis. The effect of a low protein diet was abolished by dietary L-arginine supplementation.
This study strongly implicates NO as a mediator in immune-mediated mesangial cell lysis. The data suggest that limiting NO production by limiting arginine intake might decrease glomerular injury and subsequent glomerulosclerosis.
由诱导型一氧化氮合酶从L-精氨酸产生的一氧化氮(NO)是炎症和免疫性组织损伤中的重要效应分子。研究了NO生成在肾小球系膜细胞免疫损伤中的作用以及L-精氨酸饮食限制对该损伤的影响。
通过注射与肾小球系膜细胞上抗原结合的抗胸腺细胞血清(ATS)诱导急性肾小球肾炎。随后是补体介导的系膜细胞溶解。评估在注射ATS前60分钟给予一氧化氮合酶抑制剂NG-单甲基-L-精氨酸(L-NMMA)以体内阻断NO产生对系膜细胞溶解和疾病严重程度的影响。还确定了L-精氨酸饮食限制对注射ATS后系膜细胞溶解的影响。
我们在此报告,用L-NMMA在体内阻断NO产生可使系膜细胞溶解减少90%。注射L-NMMA导致收缩压短暂升高,但并未减少ATS与系膜细胞的结合或单核细胞/巨噬细胞向肾小球的募集,表明L-NMMA预处理并未因肾小球灌注不足而限制损伤。ATS诱导的蛋白尿和尿中亚硝酸盐排泄增加被阻止。L-NMMA治疗抑制了转化生长因子-β的肾小球表达和细胞外基质的积累。在疾病诱导前7天给予低蛋白饮食(6%),以及选择性饮食L-精氨酸限制,模拟了L-NMMA治疗,显著减少了系膜细胞溶解。饮食中补充L-精氨酸消除了低蛋白饮食的作用。
本研究强烈表明NO是免疫介导的系膜细胞溶解的介质。数据表明,通过限制精氨酸摄入来限制NO产生可能会减少肾小球损伤和随后的肾小球硬化。